CMS might let beneficiaries who use insulin take the unusual step of switching Medicare plans after the current open enrollment period ends if they choose the wrong plan because they didn’t know all plans must cap monthly out-of-pocket insulin costs at $35, a CMS spokesperson told Inside Health Policy. The insulin cost cap is not factored into the Medicare Advantage and Part D plans listed in the Medicare Plan Finder because insurers submitted bids well before the president signed...